Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Novel anti-HIV agents reported by Kumamoto

Sep. 20, 2005

Aplaviroc studies in treatment-naive HIV patients halted over liver toxicity

Sep. 19, 2005

Phase II trial of TNX-355 for HIV recommended to continue

Sep. 16, 2005

In vitro and in vivo data on novel HIV integrase inhibitor

Sep. 14, 2005

Progenics updates findings on HIV entry inhibitor PRO-140

Sep. 13, 2005

Novel anti-HIV agents reported by Shionogi and AstraZeneca

Sep. 6, 2005

CADA - a potential anti-HIV CD4-targeting microbicide

Sep. 6, 2005

Novel HIV protease inhibitors with nanomolar potency and once-daily dosing possibility

Sep. 2, 2005

MIV-210 begins phase IIa study for HIV

Sep. 2, 2005

Pharmasset earns milestone for Reverset study results

Sep. 2, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...